Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

[Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis].

Bergot E, Abiteboul D, Andréjak C, Antoun F, Barras E, Blanc FX, Bourgarit A, Charlois-Ou C, Delacourt C, Dirou S, Gerin M, Guerin S, Haustraete É, Henry B, Lucet JC, Maitre T, Morin J, Le Palud P, Pommelet V, Rivoisy C, Robert J, Veziris N, Herrmann JL.

Rev Mal Respir. 2018 Oct;35(8):852-858. doi: 10.1016/j.rmr.2018.08.007. Epub 2018 Sep 14. French. No abstract available.

PMID:
30224215
2.

[Interferon gamma release assay tests and nontuberculous mycobacteria].

Andréjak C, Barras E.

Rev Mal Respir. 2018 Oct;35(8):900-901. doi: 10.1016/j.rmr.2018.08.017. Epub 2018 Sep 13. French. No abstract available.

PMID:
30220488
3.

Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.

Sarter K, Leimgruber E, Gobet F, Agrawal V, Dunand-Sauthier I, Barras E, Mastelic-Gavillet B, Kamath A, Fontannaz P, Guéry L, Duraes Fdo V, Lippens C, Ravn U, Santiago-Raber ML, Magistrelli G, Fischer N, Siegrist CA, Hugues S, Reith W.

J Exp Med. 2016 Feb 8;213(2):177-87. doi: 10.1084/jem.20150435. Epub 2016 Jan 25.

4.

RFX transcription factors are essential for hearing in mice.

Elkon R, Milon B, Morrison L, Shah M, Vijayakumar S, Racherla M, Leitch CC, Silipino L, Hadi S, Weiss-Gayet M, Barras E, Schmid CD, Ait-Lounis A, Barnes A, Song Y, Eisenman DJ, Eliyahu E, Frolenkov GI, Strome SE, Durand B, Zaghloul NA, Jones SM, Reith W, Hertzano R.

Nat Commun. 2015 Oct 15;6:8549. doi: 10.1038/ncomms9549.

5.

RFX2 Is a Major Transcriptional Regulator of Spermiogenesis.

Kistler WS, Baas D, Lemeille S, Paschaki M, Seguin-Estevez Q, Barras E, Ma W, Duteyrat JL, Morlé L, Durand B, Reith W.

PLoS Genet. 2015 Jul 10;11(7):e1005368. doi: 10.1371/journal.pgen.1005368. eCollection 2015 Jul.

6.

Extensive remodeling of DC function by rapid maturation-induced transcriptional silencing.

Seguín-Estévez Q, Dunand-Sauthier I, Lemeille S, Iseli C, Ibberson M, Ioannidis V, Schmid CD, Rousseau P, Barras E, Geinoz A, Xenarios I, Acha-Orbea H, Reith W.

Nucleic Acids Res. 2014 Sep;42(15):9641-55. doi: 10.1093/nar/gku674. Epub 2014 Aug 7.

7.

MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.

Benasciutti E, Mariani E, Oliva L, Scolari M, Perilli E, Barras E, Milan E, Orfanelli U, Fazzalari NL, Campana L, Capobianco A, Otten L, Particelli F, Acha-Orbea H, Baruffaldi F, Faccio R, Sitia R, Reith W, Cenci S.

J Bone Miner Res. 2014 Feb;29(2):290-303. doi: 10.1002/jbmr.2090.

8.

MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells.

Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2735-40. doi: 10.1073/pnas.0811073106. Epub 2009 Feb 4.

9.

Novel function of the ciliogenic transcription factor RFX3 in development of the endocrine pancreas.

Ait-Lounis A, Baas D, Barras E, Benadiba C, Charollais A, Nlend Nlend R, Liègeois D, Meda P, Durand B, Reith W.

Diabetes. 2007 Apr;56(4):950-9. Epub 2007 Jan 17.

10.

Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes.

Krawczyk M, Leimgruber E, Seguín-Estévez Q, Dunand-Sauthier I, Barras E, Reith W.

Nucleic Acids Res. 2007;35(2):595-605. Epub 2006 Dec 15.

11.

Revisiting the specificity of the MHC class II transactivator CIITA in vivo.

Otten LA, Leibundgut-Landmann S, Huarte J, Kos-Braun IC, Lavanchy C, Barras E, Borisch B, Steimle V, Acha-Orbea H, Reith W.

Eur J Immunol. 2006 Jun;36(6):1548-58.

12.
13.

Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.

Krawczyk M, Peyraud N, Rybtsova N, Masternak K, Bucher P, Barras E, Reith W.

J Immunol. 2004 Nov 15;173(10):6200-10.

14.

The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification.

Bonnafe E, Touka M, AitLounis A, Baas D, Barras E, Ucla C, Moreau A, Flamant F, Dubruille R, Couble P, Collignon J, Durand B, Reith W.

Mol Cell Biol. 2004 May;24(10):4417-27.

15.

Chromatin remodeling and extragenic transcription at the MHC class II locus control region.

Masternak K, Peyraud N, Krawczyk M, Barras E, Reith W.

Nat Immunol. 2003 Feb;4(2):132-7. Epub 2003 Jan 13.

PMID:
12524537
16.

Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.

Matheux F, Ikinciogullari A, Zapata DA, Barras E, Zufferey M, Dogu F, Regueiro JR, Reith W, Villard J.

Mol Ther. 2002 Dec;6(6):824-9.

17.
18.
19.

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.

Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W.

Nat Genet. 1998 Nov;20(3):273-7.

PMID:
9806546
20.

[Bottle fed children with caries: dental care under general anesthesia].

Barras E.

Rev Med Suisse Romande. 1998 Jan;118(1):7-12. French. No abstract available.

PMID:
9528316
21.

Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.

Clausen BE, Waldburger JM, Schwenk F, Barras E, Mach B, Rajewsky K, Förster I, Reith W.

Immunity. 1998 Feb;8(2):143-55.

22.

RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.

Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W.

EMBO J. 1997 Mar 3;16(5):1045-55.

23.

Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency.

Villard J, Reith W, Barras E, Gos A, Morris MA, Antonarakis SE, Van den Elsen PJ, Mach B.

Hum Mutat. 1997;10(6):430-5.

PMID:
9401005
24.

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W.

Genes Dev. 1995 May 1;9(9):1021-32.

25.

RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins.

Reith W, Ucla C, Barras E, Gaud A, Durand B, Herrero-Sanchez C, Kobr M, Mach B.

Mol Cell Biol. 1994 Feb;14(2):1230-44.

26.

Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.

Reith W, Siegrist CA, Durand B, Barras E, Mach B.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):554-8.

27.

MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain.

Reith W, Herrero-Sanchez C, Kobr M, Silacci P, Berte C, Barras E, Fey S, Mach B.

Genes Dev. 1990 Sep;4(9):1528-40.

28.

Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation.

Reith W, Barras E, Satola S, Kobr M, Reinhart D, Sanchez CH, Mach B.

Proc Natl Acad Sci U S A. 1989 Jun;86(11):4200-4.

29.

Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene.

Gönczy P, Reith W, Barras E, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B.

Mol Cell Biol. 1989 Jan;9(1):296-302.

30.
31.

Hormone release by islet B cell-enriched and A and D cell-enriched populations prepared by flow cytometry.

Fletcher DJ, Grogan WM, Barras E, Weir GC.

Endocrinology. 1983 Nov;113(5):1791-8.

PMID:
6194980
32.

Pharmacological inhibition of hormonal tyrosine amino transferase induction.

Da Silva AS, Goldberg A, Barras E, Orlandi VL, Salles JM, Brentani RR.

Biochem Pharmacol. 1974 Sep 1;23(17):2455-7. No abstract available.

PMID:
4154751

Supplemental Content

Loading ...
Support Center